HT94252410938↗

The Royal Veterinary College received this grant or assistance award from Defense Health Agency: $345.7K obligated so far for military medical research and development. Its latest action was on 2026-04-24.

Key facts · data as of Oct 26, 2026

Recipient
The Royal Veterinary College
Awarding agency
Defense Health Agency (Department of Defense)
Obligated to date
$345.7K

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.

Cite this page: SpendQuery, Award HT94252410938, data as of Oct 26, 2026, https://spendquery.com/award?id=ASST_NON_HT94252410938_097

AAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING

Project Grant (B) · Defense Health Agency · to The Royal Veterinary College (UEI CUV4KZ1VZKK5) · data as of 2026-10-26

Obligated to date$345.7K4 actions
Period2024-09-10 → 2026-04-24first to last action

What it is

Program
Military Medical Research and Development (Assistance Listing 12.420)
Where the work is
GBR

Obligations by fiscal year

FY2024$51.8K
FY2026$293.9K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subrecipients: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

4 actions since 2024-09-10. Each is a modification or amendment with the money it added or took back.

DateAmendmentKindAmountWhat the agency wrote
2026-04-24P00003Revision$0AAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING UPDATE THE ORGANIZATIONAL TRANSFER TERM IN DIVISION II OF AWARD.
2026-04-17P00002Revision$293.9KAAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING TRANSFER OF AWARD FROM ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
2024-09-17P00001Revision-$293.9KAAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING MODIFICATION P00002 TRANSFER AWARD TO ROYAL VETERINARY COLLEGE
2024-09-100New award$345.7KAAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗